Both in Pharmaceuticals
Janux Therapeutics vs Jade Biosciences
Over the past year JANX returned −38.1% and JBIO returned +42.5%; their daily moves had a correlation of 0.23.
JANX −38.1% JBIO +42.5%Growth of $1, one year, split-adjusted
| Metric | JANX | JBIO |
|---|---|---|
| Price | $16.94 | $14.53 |
| Market cap | $1.04B | $923.8M |
| Today | +1.65% | −0.45% |
| 1 month | +3.9% | +0.7% |
| 6 months | +11.2% | −45.9% |
| Year to date | +22.7% | −5.9% |
| 1 year | −30.8% | +46.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −214.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 43.1× | — |
| Net cash | $970.9M | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | 47.4% | 57.0% |
| Short % of float | 13.4% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).